Composition for inhibiting CTGF expression

    公开(公告)号:US12234458B2

    公开(公告)日:2025-02-25

    申请号:US17162045

    申请日:2021-01-29

    Applicant: LEMONEX INC.

    Inventor: Cheol Hee Won

    Abstract: A composition according to an embodiment of the present invention includes nucleic acid molecules which are capable of effectively inhibiting the expression level of connective tissue growth factor (CTGF) and collagen by RNA interference (RNAi), thereby preventing or treating a variety of fibroproliferative diseases due to overexpression of CTGF or collagen.

    Pharmaceutical composition and functional health food for preventing or treating macular degeneration

    公开(公告)号:US11633447B2

    公开(公告)日:2023-04-25

    申请号:US17258312

    申请日:2019-07-09

    Applicant: LEMONEX INC.

    Abstract: A composition according to an embodiment of the present disclosure includes a banaba leaf extract, a guava leaf extract or a mixture thereof. The composition inhibits photooxidation of A2E due to blue light, inhibits a death of retinal pigment epithelial cells induced by blue light, and inhibits a damage to outer nuclear layers of visual cells in an animal model with blue light-induced macular degeneration, and thus can be beneficially used as a composition for preventing or treating macular degeneration and as a health functional food for preventing or alleviating macular degeneration.

Patent Agency Ranking